MétaCan
Menu
Back to cohort
Record W4405467039 · doi:10.1016/s1473-3099(24)00588-7

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis

2024· article· en· W4405467039 on OpenAlexaff
Maria Garcia Quesada, Meagan E. Peterson, Julia C. Bennett, Kyla Hayford, Scott L. Zeger, Yangyupei Yang, Marissa K. Hetrich, Daniel R. Feikin, Adam L. Cohen, Anne von Gottberg, Mark van der Linden, Nina M. van Sorge, Lúcia Helena de Oliveira, Sara de Miguel, İnci Yıldırım, Didrik F. Vestrheim, Jennifer R. Verani, Emmanuelle Varon, Palle Valentiner‐Branth, Georgina Tzanakaki, Nadja Sinkovec Zorko, Lena Setchanova, Fatima Serhan, Kevin J Scott, J. Anthony G. Scott, Camelia Savulescu, Larisa Savrasova, Rita Reyburn, Kazunori Oishi, J. Pekka Nuorti, Daniela Napoli, Jason M. Mwenda, Carmen Muñoz‐Almagro, Eva Morfeldt, Kimberley McMahon, Allison McGeer, Lucia Mad'arová, Grant Mackenzie, Maria Eugenia León, Shamez Ladhani, Karl G. Kristinsson, Jana Kozáková, Jackie Kleynhans, Nicola P. Klein, James D. Kellner, Sanjay Jayasinghe, Pak‐Leung Ho, Markus Hilty, Marcella Harker‐Jones, Laura L. Hammitt, Marta Grgič-Vitek, Charlotte Gilkison, Ryan Gierke, Neil French, Idrissa Diawara, Stefanie Desmet, Philippe De Wals, Tine Dalby, Ron Dagan, Mary Corcoran, Edoardo Colzani, Grettel Chanto Chacón, Jesús Castilla, Romina Camilli, Michelle Ang, Krow Ampofo, Samanta Cristine Grassi Almeida, Pedro Alarcón, Katherine L. O’Brien, Maria Deloria Knoll

Bibliographic record

VenueThe Lancet Infectious Diseases · 2024
Typearticle
Languageen
FieldMedicine
TopicPneumonia and Respiratory Infections
Canadian institutionsUniversité LavalUniversity of CalgaryAlberta Health ServicesUniversity Health Network
FundersNational Institute of Allergy and Infectious DiseasesWorld Health OrganizationBill and Melinda Gates Foundation
KeywordsPneumococcal diseaseSerotypePneumococcal conjugate vaccineConjugateVirologyStreptococcus pneumoniaeMedicineDistribution (mathematics)Disease surveillancePneumococcal infectionsDiseaseBiologyMicrobiologyMathematicsInternal medicineAntibiotics

Abstract

fetched live from OpenAlex

BACKGROUND: Widespread use of pneumococcal conjugate vaccines (PCVs) has reduced vaccine-type invasive pneumococcal disease (IPD). We describe the serotype distribution of IPD after extensive use of ten-valent PCV (PCV10; Synflorix, GSK) and 13-valent PCV (PCV13; Prevenar 13, Pfizer) globally. METHODS: IPD data were obtained from surveillance sites participating in the WHO-commissioned Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project that exclusively used PCV10 or PCV13 (hereafter PCV10 and PCV13 sites, respectively) in their national immunisation programmes and had primary series uptake of at least 70%. Serotype distribution was estimated for IPD cases occurring 5 years or more after PCV10 or PCV13 introduction (ie, the mature period when the serotype distribution had stabilised) using multinomial Dirichlet regression, stratified by PCV product and age group (<5 years, 5-17 years, 18-49 years, and ≥50 years). FINDINGS: The analysis included cases occurring primarily between 2015 and 2018 from 42 PCV13 sites (63 362 cases) and 12 PCV10 sites (6806 cases) in 41 countries. Sites were mostly high income (36 [67%] of 54) and used three-dose or four-dose booster schedules (44 [81%]). At PCV10 sites, PCV10 serotypes caused 10·0% (95% CI 6·3-12·9) of IPD cases in children younger than 5 years and 15·5% (13·4-19·3) of cases in adults aged 50 years or older, while PCV13 serotypes caused 52·1% (49·2-65·4) and 45·6% (40·0-50·0), respectively. At PCV13 sites, PCV13 serotypes caused 26·4% (21·3-30·0) of IPD cases in children younger than 5 years and 29·5% (27·5-33·0) of cases in adults aged 50 years or older. The leading serotype at PCV10 sites was 19A in children younger than 5 years (30·6% [95% CI 18·2-43·1]) and adults aged 50 years or older (14·8% [11·9-17·8]). Serotype 3 was a top-ranked serotype, causing about 9% of cases in children younger than 5 years and 14% in adults aged 50 years or older at both PCV10 and PCV13 sites. Across all age and PCV10 or PCV13 strata, the proportion of IPD targeted by higher-valency PCVs beyond PCV13 was 4·1-9·7% for PCV15, 13·5-36·0% for PCV20, 29·9-53·8% for PCV21, 15·6-42·0% for PCV24, and 31·5-50·1% for PCV25. All top-ten ranked non-PCV13 serotypes are included in at least one higher-valency PCV. INTERPRETATION: The proportion of IPD due to serotypes included in PCVs in use was low in mature PCV10 and PCV13 settings. Serotype distribution differed between PCV10 and PCV13 sites and age groups. Higher-valency PCVs target most remaining IPD and are expected to extend impact. FUNDING: Bill & Melinda Gates Foundation as part of the WHO Pneumococcal Vaccines Technical Coordination Project.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.735

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.297
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations76
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet Infectious DiseasesSame topicPneumonia and Respiratory InfectionsFrench-language works237,207